1003-3734
2013 Issue 18
bian zhe tui jian
wang yu mei ;
wang yu mei ;
..............page:2098
..............page:2102
..............page:2103-2104
International Pharmacovigilance Flash
ben kan ;
ben kan ;
..............page:2105-2106
..............page:2107-2110
Brief introduction and developmental trends of the biologics approved by the FDA between 2010 and 2012
ZHOU Feng;LIU Xue-mei;HU Chang-hua;College of Pharmacy;Southwest University;Chongqing Engineering Research Center for Pharmaceutical Process and Quality Control;
ZHOU Feng;LIU Xue-mei;HU Chang-hua;College of Pharmacy;Southwest University;Chongqing Engineering Research Center for Pharmaceutical Process and Quality Control;
..............page:2111-2115+2141
Analysis on new trends of the global biopharmaceutical industry
XU Mei-ting;YANG Yue;College of Business Administration;Shenyang Pharmaceutical University;
XU Mei-ting;YANG Yue;College of Business Administration;Shenyang Pharmaceutical University;
..............page:2116-2119+2125
Current situation and future trend of international drug innovation
YUAN Li;YANG Yue;College of Business Administration;Shenyang Pharmaceutical University;
YUAN Li;YANG Yue;College of Business Administration;Shenyang Pharmaceutical University;
..............page:2120-2125
Consideration on the use of single-arm clinical trial data to support the import registration of drugs
ZHANG Hong;GAO Chen-yan;CHEN Xiao-yuan;YANG Zhi-min;Center for Drug Evaluation;China Food and Drug Administration;
ZHANG Hong;GAO Chen-yan;CHEN Xiao-yuan;YANG Zhi-min;Center for Drug Evaluation;China Food and Drug Administration;
..............page:2126-2129
Simultaneous determination of five phenolic acids in Fufang Danshen tablets by quantitative analysis of multi-components by single marker
WU Di;YE Qiu-xiong;LI Chu-yuan;Institute for Traditional Chinese Medicine Research;Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited;
WU Di;YE Qiu-xiong;LI Chu-yuan;Institute for Traditional Chinese Medicine Research;Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited;
..............page:2130-2135+2173
Formulation optimization of salvianolic acids sustained release pellets by central composite design-response surface methodology
LI Na;LI Xiao-fang;CUI Han-ming;Guang’anmen Hospital;China Academy of Chinese Medical Science;Chengdu University of TCM;
LI Na;LI Xiao-fang;CUI Han-ming;Guang’anmen Hospital;China Academy of Chinese Medical Science;Chengdu University of TCM;
..............page:2136-2139+2185
FDA Generic Drug User Fee Act(GDUFA) for fiscal year 2014
Garth Boehm;YAO Li-xin;ZHENG Qiang;Center for Pharmaceutical Information and Engineering Research;College of Engineering;Peking University;Center for Pharmaceutical Information and Engineering Research;College of Engineering;Peking University;Department of Industry Engineering and Management;College of Engineering;Peking University;
Garth Boehm;YAO Li-xin;ZHENG Qiang;Center for Pharmaceutical Information and Engineering Research;College of Engineering;Peking University;Center for Pharmaceutical Information and Engineering Research;College of Engineering;Peking University;Department of Industry Engineering and Management;College of Engineering;Peking University;
..............page:2140-2141
Recent advances in “nanoantibiotics” drug delivery system
HE Shao-long;YANG Mei-yan;GAO Chun-sheng;JIN Hai-ming;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;School of Pharmacy;Central South University;Parmaceutical College;Henan University;
HE Shao-long;YANG Mei-yan;GAO Chun-sheng;JIN Hai-ming;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;School of Pharmacy;Central South University;Parmaceutical College;Henan University;
..............page:2142-2146+2194
Advances in research of cell-based drug screening by microfluidic chip
SUN Duan-ping;LI Yin-bao;PAN Jian-bin;CHEN Zuan-guang;School of Pharmaceutical Sciences;Sun Yat-sen University;
SUN Duan-ping;LI Yin-bao;PAN Jian-bin;CHEN Zuan-guang;School of Pharmaceutical Sciences;Sun Yat-sen University;
..............page:2147-2151+2158
Progress in research of new breviscapine dose forms and their new preparation techniques
CUI Ya-nan;GUAN Hua;ZHANG Qiang;School of Pharmacy;Jining Medical Colledge;School of Pharmacy;Peking University Health Science Center;
CUI Ya-nan;GUAN Hua;ZHANG Qiang;School of Pharmacy;Jining Medical Colledge;School of Pharmacy;Peking University Health Science Center;
..............page:2152-2158
A clinical trial for evaluating efficacy and safety of amlodipine besylate / atorvastatin calcium in treating hypertension complicated with hyperlipidemia
QI Li-tong;SUN Yue-min;LI Shu-ren;YUAN Hong;LI Jun-xia;ZHONG Guo-qiang;LI Hong-wei;XIONG Long-gen;ZHAO Feng;HUO Yong;Department of Cardiology;Peking University First Hospital;General Hospital of Tianjin Medical University;People’s Hospital of Hebei Province;Central South University;Third Xiangya Hospital;The Chinese People’s Liberation Army Bethune International Peace Hospital;Guangxi Medical University First Hospital;Capital Medical University;Beijing Friendship Hospital;Guangzhou Medical College Second Hospital;
QI Li-tong;SUN Yue-min;LI Shu-ren;YUAN Hong;LI Jun-xia;ZHONG Guo-qiang;LI Hong-wei;XIONG Long-gen;ZHAO Feng;HUO Yong;Department of Cardiology;Peking University First Hospital;General Hospital of Tianjin Medical University;People’s Hospital of Hebei Province;Central South University;Third Xiangya Hospital;The Chinese People’s Liberation Army Bethune International Peace Hospital;Guangxi Medical University First Hospital;Capital Medical University;Beijing Friendship Hospital;Guangzhou Medical College Second Hospital;
..............page:2159-2163
Evaluation of atorvastatin and clopidogrel interaction by HPLC-MS /MS in healthy volunteers
WANG Yan-hui;ZHANG Hao;WEI Hong-shun;MENG Xiao-dong;FANG Yan;LI Qi;WANG Jing;PEI Yi -xuan;Intensive Care Unit;Second Provincial People’s Hospital of Gansu;Cardiology Department;Second Provincial People’s Hospital of Gansu;Emergency Department;Second Provincial People’s Hospital of Gansu;
WANG Yan-hui;ZHANG Hao;WEI Hong-shun;MENG Xiao-dong;FANG Yan;LI Qi;WANG Jing;PEI Yi -xuan;Intensive Care Unit;Second Provincial People’s Hospital of Gansu;Cardiology Department;Second Provincial People’s Hospital of Gansu;Emergency Department;Second Provincial People’s Hospital of Gansu;
..............page:2164-2167
Isolation and identification of endophytic fungus LM033 obtained from Moringaoleifera Lam. and biological activity of the metabolites
CAI Qing-xiu;ZHAO Jin-hao;WANG Jia-ying;WANG Li-wei;ZHANG Chu-long;Key Laboratory for Green Pharmaceutical Technologies and Related Equipment;Ministry of Education;Institute of Pesticide and Environmental Toxicology;Zhejiang University;Institute of Biotechnology;Zhejiang University;Department of Pharmaceutical Science;College of Medicine and Public Health Management;Hangzhou Normal University;
CAI Qing-xiu;ZHAO Jin-hao;WANG Jia-ying;WANG Li-wei;ZHANG Chu-long;Key Laboratory for Green Pharmaceutical Technologies and Related Equipment;Ministry of Education;Institute of Pesticide and Environmental Toxicology;Zhejiang University;Institute of Biotechnology;Zhejiang University;Department of Pharmaceutical Science;College of Medicine and Public Health Management;Hangzhou Normal University;
..............page:2168-2173
Preparation,characterization and pharmacodynamic evaluation in vitro of norcantharidin-loaded folate-conjugated stealth niosomes
LIU Hong-yue;YANG Hong;WU Xiu-feng;MAO Hua-jian;GONG Zhu-ping;WAN Zhi-hui;ZHANG Wei;WU You-ming;GU Rui-nan;HAN Nan-nan;College of Pharmaceutical Sciences;Soochow University;
LIU Hong-yue;YANG Hong;WU Xiu-feng;MAO Hua-jian;GONG Zhu-ping;WAN Zhi-hui;ZHANG Wei;WU You-ming;GU Rui-nan;HAN Nan-nan;College of Pharmaceutical Sciences;Soochow University;
..............page:2174-2178
Preparation and quality control of entecavir dispersible tablets
LI Dong-mei;WU Yan;SHI Sheng-yi;ZHANG Fu-cheng;Hebei North University;The Air Force General Hospital;Shenyang Pharmaceutical University;
LI Dong-mei;WU Yan;SHI Sheng-yi;ZHANG Fu-cheng;Hebei North University;The Air Force General Hospital;Shenyang Pharmaceutical University;
..............page:2179-2185
Preparation and quality evaluation of aspirin and hydrotalcite double-layer tablets
XIAO Hui;BAI Jian;HOU Peng;CAI Zheng-jun;ZHANG Yue;Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co.;Ltd.;State Key Laboratories of Natural and Biomimetic Drugs;Peking University;School of Chinese Pharmacy;Beijing University of Chinese Medicine;
XIAO Hui;BAI Jian;HOU Peng;CAI Zheng-jun;ZHANG Yue;Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co.;Ltd.;State Key Laboratories of Natural and Biomimetic Drugs;Peking University;School of Chinese Pharmacy;Beijing University of Chinese Medicine;
..............page:2186-2189
Preparation,releasing feature and local biological safety evaluation of bone implanted sustained-releasing levofloxacin tablets
XIU Han;CAO Hong;WANG Jian-fei;PING Jie;LIU Lian;CHEN Liao-bin;WANG Hui;Department of Pharmacology;Basic Medical School;Wuhan University;Department of Orthopaedic Surgery;Zhongnan Hospital;Wuhan University;
XIU Han;CAO Hong;WANG Jian-fei;PING Jie;LIU Lian;CHEN Liao-bin;WANG Hui;Department of Pharmacology;Basic Medical School;Wuhan University;Department of Orthopaedic Surgery;Zhongnan Hospital;Wuhan University;
..............page:2190-2194
Preparation of cyclosporine A ophthalmic emulsions trapped in situ gels and the release mechanism in vitro
LI Shi;YI Chun-fang;WANG Zhi-kun;XUE Xiao;WANG Dong-kai;School of Pharmacy;Shenyang Pharmaceutical University;
LI Shi;YI Chun-fang;WANG Zhi-kun;XUE Xiao;WANG Dong-kai;School of Pharmacy;Shenyang Pharmaceutical University;
..............page:2195-2200
Stability measurement of alprostadil injections’ globule in a compatible experiment
PAN Wei-xiang;LIU Jie;HE Jun;YANG Ya-ni;BIAN Wei;ZHANG Wei-wei;National Pharmaceutical Engineering & Research Center;China State Institute of Pharmaceutical Industry;
PAN Wei-xiang;LIU Jie;HE Jun;YANG Ya-ni;BIAN Wei;ZHANG Wei-wei;National Pharmaceutical Engineering & Research Center;China State Institute of Pharmaceutical Industry;
..............page:2201-2205+2214
Determination of related substances in compound chlorzoxazone capsules by HPLC
WANG Xiao-bing;XU Yu-wen;ZHENG Jing;LENG Jia-wei;Shandong Institute for Food and Drug Control;
WANG Xiao-bing;XU Yu-wen;ZHENG Jing;LENG Jia-wei;Shandong Institute for Food and Drug Control;
..............page:2206-2209+2218
Impurities in raw material of dasatinib
LIANG Xiao-dong;WANG Shu-juan;ZHANG Hua;GU Hong-juan;Sinopharm A-Think Pharmaceutical Co.;Ltd.;Institute of Chemical Engineering;Changchun University of Technology;College of Chemical Engineering and Material;Heilongjiang University;
LIANG Xiao-dong;WANG Shu-juan;ZHANG Hua;GU Hong-juan;Sinopharm A-Think Pharmaceutical Co.;Ltd.;Institute of Chemical Engineering;Changchun University of Technology;College of Chemical Engineering and Material;Heilongjiang University;
..............page:2210-2214
Case report and analysis of allopurinol-caused ADR /ADE in 60 patients
WU Hai-wen;WANG Chun-ting;ADR Monitoring Center of Ningbo;National ADR Monitoring Center;
WU Hai-wen;WANG Chun-ting;ADR Monitoring Center of Ningbo;National ADR Monitoring Center;
..............page:2215-2218
Two cases of meropenem-induced severe bullous drug eruptions and the literature analysis
XU Jing;LI Tian-yuan;XU Jin;QIU Jin-chun;LU Xin;LIAO Qing-chuan;Nanjing Children’s Hospital Affiliated to Nanjing Medical University;
XU Jing;LI Tian-yuan;XU Jin;QIU Jin-chun;LU Xin;LIAO Qing-chuan;Nanjing Children’s Hospital Affiliated to Nanjing Medical University;
..............page:2219-2222
..............page:2222